Clinical Trials
334 trialsLN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
M.D. Anderson Cancer Center
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Fox Chase Cancer Center
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Case Comprehensive Cancer Center
PRO-NEM1
Centre Hospitalier Universitaire Dijon
XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
Northwestern University
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
Barts & The London NHS Trust
Long-Term Longitudinal QoL in Patients Undergoing EEA
Ohio State University
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
M.D. Anderson Cancer Center
PTC-RFA
University Health Network, Toronto
Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
Universitaire Ziekenhuizen KU Leuven
Tumor HI
Rezolute
The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support
M.D. Anderson Cancer Center
NET-TIME
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
University of Wisconsin, Madison
ADJUPANET
Gustave Roussy, Cancer Campus, Grand Paris
ISOMAB
University Hospital, Bordeaux
Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
Memorial Sloan Kettering Cancer Center
Multicenter Trial of ESK981 in Patients With Select Solid Tumors
University of Michigan Rogel Cancer Center
ELEGANCE
Nantes University Hospital
Clinical Utility of Preoperative Thyroid GuidePx® Testing
University of Calgary
EUSRFAINSU
Sahlgrenska University Hospital
CLERAD-PROBE
University of Wuerzburg
DOTATOC PET/CT for Imaging NET Patients
British Columbia Cancer Agency
LEVEL
Grupo Espanol de Tumores Neuroendocrinos
PLANE-PC
University of Michigan Rogel Cancer Center
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
University of Alberta
TRICAR
Queen Mary University of London
Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism
Haukeland University Hospital
Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints
Arizona State University
The Impact of Self-assessment on Hydration
Arizona State University
German Adrenocortical Carcinoma Registry
University of Wuerzburg
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
University of Wuerzburg
Evaluation of Side Effects of Mitotane
University of Wuerzburg
Adrenal Tumors - Pathogenesis and Therapy
University of Wuerzburg
IoN
University College, London
Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver
Memorial Sloan Kettering Cancer Center
Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy
Shanghai 6th People's Hospital
Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)
Shanghai 6th People's Hospital
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
Columbia University
iCaRe2
University of Nebraska
PRO-COMAND
University of Pisa
AI in Endoscopic Transsphenoidal Surgery
University College, London
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
M.D. Anderson Cancer Center
Lumed
University Hospital, Basel, Switzerland
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
Memorial Sloan Kettering Cancer Center
ALPINE 2
Technische Universität Dresden
18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma
St. Jude Children's Research Hospital
Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas
Grupo Espanol de Tumores Neuroendocrinos
The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]
Samsung Medical Center
SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)
University of Miami